GES

University of Miami Miller School of Medicine Report Supports Value of Food Intolerance Testing TORONTO, March 22, 2012 /CNW/ - Gemoscan Canada, Inc.   (MUN: 1GE) welcomes a new study published in the Journal of Obesity & Weight Loss Therapy that points to food sensitivity as a key culprit in obesity. The study, led by John E. Lewis, Ph.D., Associate Professor of Psychiatry and Behavioral Sciences and Associate Director of the Medical Wellness Center at the University of Miami Miller School of Medicine, and co-authored by Judi M. Woolger, M.D., Assistant Professor of Medicine, and Janet Konefal, Ph.D., Associate Professor of Psychiatry and Behavioral Sciences and Assistant Dean for Complementary and Integrative Medicine assessed the impact of a food sensitivity test "in combination with a food elimination diet - on weight, body mass index, and quality of life in people who wanted to lose weight and/or were overweight," according to published reports. Significantly, the study suggests that a person's food intolerances can be identified by a simple blood test. The HEMOCODE(TM) Food Intolerance System, available at Rexall(tm/md) and Pharma Plus stores across Canada, as well as online and via medical professionals, is a comprehensive naturopathic nutrition program to help Canadians identify and manage food sensitivities. The process begins with a simple non-invasive finger stick test.  Using a drop of blood, the system scans the blood for immuno-based reactions to common foods and additives. "According to the study from the University of Miami, subjects lost approximately one pound per week after eliminating foods that they reacted to," said Dr. Mubina Jiwa, Assistant Professor at the Canadian College of Naturopathic Medicine. "In my practice, I find that patients with identified food intolerances via a system such as HEMOCODE(TM) not only lose weight, but can manage a series of health issues ranging from migraines to digestive discomfort. There is no question that certain foods cause immuno-based responses in a large percentage of the population." The HEMOCODE(TM) Food Intolerance System is more than a test; it delivers a personalized program to insure food sensitivity results are not simply left to the individual for interpretation and implementation. Pharmacists and health care practitioners, under supervision of licensed Doctors of Naturopathic Medicine, will explain and guide each person through the various elements of the HEMOCODE(TM)system. Following the laboratory blood evaluation, personalized reports detailing potentially offending foods and suggestions for their elimination and substitution are returned to the pharmacist or practitioner within 7-10 business days, for review and discussion with each individual. Personalized recipes, as well as specific vitamin and supplement recommendations form part of HEMOCODE(TM)'s unique, comprehensive and balanced approach to diet and food sensitivity management. Understanding the cause and effect of food intolerances and making the necessary dietary adjustments, can make it easier to maintain a healthy and active lifestyle. The Miller School study tested 115 foods on 120 subjects aged 18 and over. Study subjects who were administered a blood test to determine potential food intolerances were then asked to eliminate the offending foods from their diets for varying periods of time over the course of 3 months. The study found that in addition to "positive changes associated with body composition, participants noted substantial subjective improvements in both physical and mental quality of life." Dr. Jiwa added, "These findings are consistent with what I've seen in my practice, and thousands of people who use food intolerance analysis as a way to manage overall wellness. Often, people can re-introduce the foods that they are intolerant to after the body has a chance to recover. I'm pleased that there are more studies being done to promote this important wellness tool." Nearly 30% of the population suffers from food intolerances and sensitivities. Dr. Jiwa warns that "self-diagnosis" can often lead to the removal of important nutrients from a diet and suggests seeing your health care practitioner on a regular basis. For more information please visit www.hemocode.com. ABOUT THE HEMOCODE(TM) FOOD INTOLERANCE SYSTEM The HEMOCODE(TM) Food Intolerance System is a personalized naturopathic nutritional program that promotes dietary well-being.  It uses patented technology and services to provide consultation and recommendations to simplify the management of food sensitivities. The HEMOCODE(TM) Food Intolerance System is one of a growing number of wellness services and products offered by pharmacies as complementary medical choices. Complementary medicine is an adjunct to conventional medical practice, incorporating alternative modalities and therapies with a focus on lifestyle and wellness. A statistically significant base of practitioners and those using HEMOCODE(TM) report improved dietary wellness and satisfaction. ABOUT GEMOSCAN CANADA, INC. Founded in 2003, Gemoscan Canada, Inc. owns and markets the HEMOCODE(TM) Food Intolerance System, a personalized naturopathic nutritional program that uses its own patented technology and services to detect and provide recommendations for the management of immuno-based food intolerances.   The HEMOCODE(TM) Food Intolerance System was designed to take the guesswork out of deciphering what variety of common foods and additives can potentially offend and adversely affect personal wellness. Customer-specific reports, nutritional guidelines and recipe books are accompanied by consultation with health-care specialists. Gemoscan trades on the Toronto Venture Stock Exchange under the symbol GES and is quoted on the Munich Stock Exchange under the ticker 1GE. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this media statement Forward-Looking Information This news release contains certain "forward-looking information". All statements, other than statements of historical fact that address activities, events or developments that Gemoscan believes, expects or anticipates will or may occur in the future. These forward-looking statements reflect the current expectations or beliefs of Gemoscan based on information currently available to Gemoscan. Forward-looking statements are subject to a number of significant risks and uncertainties and other factors that may cause the actual results of Gemoscan to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Gemoscan. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Gemoscan disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Although Gemoscan believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein. Gemoscan Canada, Inc. CONTACT: For media information please contact:Naomi StrasserAerial Communications Group416.787.6577naomi@aerialpr.comFor investors and analysts please contact :Ann HawleyVP Investor RelationsGemoscan Canada, Inc.416.650.1200ahawley@hemocode.comwww.gemoscan.ca

Copyright